Data / Form D filings / Veralox Therapeutics Inc.
Veralox Therapeutics Inc.: Form D filings
Veralox Therapeutics Inc., a biotechnology company in Frederick, MD, filed 3 Form D notices with the SEC between 2019 and 2023. The latest, on June 21, 2023, reports $24 million sold of a $25 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4539 METROPOLITAN COURT, Frederick, MD, 21704
- Phone
- (301) 360-3502
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2018
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1777474
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 21, 2023 | New notice | $24,999,971 | $24,013,521 | $986,450 | 14 | Jun 1, 2023 | sec.gov |
| Jul 7, 2021 | New notice | $22,750,000 | $14,437,500 | $8,312,500 | 17 | Jun 10, 2021 | sec.gov |
| May 22, 2019 | New notice | $4,000,000 | $1,460,000 | $2,540,000 | 6 | May 10, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Megan Krench | Director | |
| Alex Martin | Director | |
| Benjamin Scruggs | Director | |
| Jamie Stiff | Director | |
| Katie Ellias | Director | |
| Jonathan Mow | Executive Officer, Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Jun 19, 2023 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Veralox Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.